Hematologists & Oncologists from Across Country Met to Discuss Latest Updates in Care On August 4-5, 2023, the Binaytara…
This week, The Cancer News had the opportunity to connect with three authors (Dr. Aju Mathew, Sruti Ranganathan, and Dr.…
On June 20, 2023, the U.S. Food and Drug Administration approved talazoparib (Talzenna, Pfizer, Inc.) in combination with enzalutamide for…
Janakpurdham, Nepal, April 27, 2022 – The Binaytara Foundation hosted its Fourth International Cancer Congress on April 16, bringing together…
Oncologists Interested in Improving Access to Cancer Care Encouraged to Apply Are you an oncologist who is passionate about educating…
Faculty highlight, Dr. Joseph Rosales!
ASH Review Portland, Highlights from SABCS, and Thoracic Oncology San Diego The Binaytara Foundation is facilitating three conferences with varying…
Meet Chris Nevala-Plagemann, MD, Katie Kerrigan, DO, and Theresa Werner, MD! In this week's faculty highlight, we present Drs. Chris…
Senior Fellows and Early Career Oncologists Interested in Cancer Health Disparities are Encouraged to Apply Interested in being mentored by…
Submit Your Research for Presentation at Our Cancer Disparities Summit The Binaytara Foundation invites you to submit your research for…